Business Model
25%PMI generates durable revenue from addictive nicotine demand across combustibles (58.5% of FY2025 revenue) and smoke-free (41.5%, up from 24.2% in FY2020). Geographic breadth across 180+ markets and five consecutive years of volume growth anchor forward visibility, though product exposure remains concentrated in a single demand category.
Competitive Advantages
40%Brand equity in Marlboro, IQOS, and ZYN supports above-inflation pricing across multiple recent years. IQOS holds about 76% of the global heat-not-burn category on the strength of $14B of smoke-free R&D investment since 2008. Switching costs and network effects are structurally weak for nicotine products.
Pro dimensions
Competitive Advantages · Management · Risk Assessment
Register free to unlock the full analysis of every stock in the catalog — no card required.